Rashmi Ravichandran

机构：University of Washington, Seattle University · ORCID：0000-0002-2630-7487

发表论文 75 篇 · 总被引 4638 次 · h-index 29

代表论文

• Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines (2021 · Cell · 被引 195)
• Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice (2022 · Science Translational Medicine · 被引 122)
• Preclinical proof of principle for orally delivered Th17 antagonist miniproteins (2024 · Cell · 被引 95)
• A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy (2022 · Nature Biotechnology · 被引 84)
• Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice (2022 · npj Vaccines · 被引 61)
• Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccine (2022 · Science Translational Medicine · 被引 60)